Related Experiment Video
Updated: Jul 17, 2026
08:38
Habituation and Prepulse Inhibition of Acoustic Startle in Rodents
Published on: September 1, 2011
Hypocretin deficiency in Prader-Willi syndrome
S Nevsimalova1, J Vankova, I Stepanova
1Department of Neurology, First Medical Faculty, Charles University, Prague, Czech Republic. snevsi@lf1.cuni.cz
European Journal of Neurology
|December 23, 2004
Summary
Prader-Willi syndrome (PWS) patients exhibit low hypocretin-1 levels, linked to hypothalamic dysfunction and fragmented sleep. This deficiency correlates with excessive daytime sleepiness in PWS.
Area of Science:
- Neuroscience
- Endocrinology
- Genetics
Background:
- Prader-Willi syndrome (PWS) is a complex genetic disorder characterized by hyperphagia, obesity, developmental delay, and sleep disturbances.
- The hypocretin (orexin) system, originating in the hypothalamus, plays a crucial role in regulating sleep-wake cycles and appetite.
- Investigating the hypocretin system's involvement in PWS may elucidate the mechanisms behind its associated sleep abnormalities.
Observation:
- Four genetically confirmed PWS patients underwent polysomnography (PSG), multiple sleep latency test (MSLT), HLA typing, and cerebrospinal fluid (CSF) hypocretin-1 (Hcrt-1) level measurement.
- Patients displayed extreme obesity, dysmorphogenetic features, and fragmented nocturnal sleep with low efficiency.
- Sleep-disordered breathing, including hypopnea and apnea, increased with age, while excessive daytime sleepiness (EDS) was present in only two patients without cataplexy.
Findings:
- CSF Hcrt-1 levels were significantly reduced in PWS patients (164 pg/ml) compared to healthy controls (265.8 pg/ml), P=0.02.
- Reduced CSF Hcrt-1 levels correlated with the severity of excessive daytime sleepiness (EDS) in PWS patients.
- Human leukocyte antigen (HLA) DQB1*0602 positivity was observed in two patients, with the other two being negative.
Implications:
- Hypothalamic dysfunction, specifically a deficiency in the hypocretin (orexin) system, may contribute to sleep disturbances and excessive daytime sleepiness in Prader-Willi syndrome.
- These findings suggest a potential therapeutic target for managing sleep issues in PWS.
- Further research is warranted to explore the precise mechanisms linking hypocretin deficiency to PWS pathophysiology and sleep abnormalities.
Related Concept Videos
01:24Sleep-Wake Cycles
Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
01:07Narcolepsy
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
01:22Diabetes Insipidus II: Pathophysiology
Normally, water balance is maintained through three interconnected mechanisms: the hypothalamic thirst center, the synthesis and release of antidiuretic hormone (ADH, or vasopressin), and the kidneys' responsiveness to this hormone. ADH is synthesized in the hypothalamus, released from the posterior pituitary, and acts on the distal nephron, allowing water reabsorption and concentrated urine production.Diabetes Insipidus and Its TypesIn diabetes insipidus (DI), this regulatory system is...
01:26Cushing Syndrome I: Introduction
Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
01:19Cushing Syndrome II: Pathophysiology
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
01:21Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...